Expertise in
33
conditions

Dr. Rowena Gonzales

Internal Medicine
Robert W. Edwards III MD Inc.
218 Undercliff Ter, 
Princeton, WV 
Expertise in
33
conditions
Robert W. Edwards III MD Inc.
218 Undercliff Ter, 
Princeton, WV 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rowena Gonzales is an Internal Medicine provider in Princeton, West Virginia. Dr. Gonzales is highly rated in 33 conditions, according to our data. Her top areas of expertise are Gastric Lymphoma, Pleuropulmonary Blastoma, Lung Cancer, Bone Marrow Aspiration, and Gastrostomy.

Her clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in WV
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Robert W. Edwards III MD Inc.
218 Undercliff Ter, Princeton, WV 24740

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Procedure
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer With Recurrence Score (RS) of 25 or Less. RxPONDER: A Clinical Trial Rx for Positive Node, Endocrine Responsive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 25, 2025
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Exemestane, Letrozole, Systemic Chemotherapy
Study Phase: Phase 3
Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastatectomy
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2025
Intervention Type: Procedure, Drug, Other
Study Drug: Pazopanib Hydrochloride
Study Phase: Phase 3
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer (COBRA)
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer (COBRA)
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2025
Intervention Type: Drug, Other
Study Drugs: Capecitabine, 5-Fluorouracil, Leucovorin, Oxaliplatin
Study Phase: Phase 2/Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 03, 2024
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Expertise in
39
conditions
Dr. Birgit A. Arb
Hematology Oncology | Oncology | Hematology
Expertise in
39
conditions
Dr. Birgit A. Arb
Hematology Oncology | Oncology | Hematology

Lewis Gale Physicians LLC

2400 Lee Hwy N, 
Pulaski, VA 
 (29.3 miles away)
540-444-4430
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Birgit Arb is a Hematologist Oncology specialist and an Oncologist in Pulaski, Virginia. Dr. Arb is highly rated in 39 conditions, according to our data. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Arb is currently accepting new patients.

Expertise in
24
conditions
Dr. Essam Y. Malaty
Hematology Oncology | Hematology | Oncology
Expertise in
24
conditions
Dr. Essam Y. Malaty
Hematology Oncology | Hematology | Oncology

Princeton Community Hospital Assn. Inc.

122 12th St, 
Princeton, WV 
 (1.2 miles away)
304-487-7936
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Essam Malaty is a Hematologist Oncology specialist and a Hematologist in Princeton, West Virginia. Dr. Malaty is highly rated in 24 conditions, according to our data. His top areas of expertise are Anemia, Colorectal Cancer, Familial Colorectal Cancer, and Breast Cancer. Dr. Malaty is currently accepting new patients.

Expertise in
32
conditions
Dr. Joseph D. Mock
Hematology Oncology | Hematology | Oncology
Expertise in
32
conditions
Dr. Joseph D. Mock
Hematology Oncology | Hematology | Oncology

Oncology And Hematology Associates Of Southwest Virginia Inc

187 Skylar Dr, 
Lewisburg, WV 
 (45.3 miles away)
304-647-3500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joseph Mock is a Hematologist Oncology specialist and a Hematologist in Lewisburg, West Virginia. Dr. Mock is highly rated in 32 conditions, according to our data. His top areas of expertise are Hemochromatosis, Acute Mountain Sickness, Childhood Iron Deficiency Anemia, and Iron Deficiency Anemia. Dr. Mock is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gonzales's expertise for a condition
ConditionClose
    View All 27 Advanced Conditions
    View All 115 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile